NR3C1 and myeloid sarcoma: One study analyzed the NR3C1 polymorphism, expression of glucocorticoid receptor (GR) isoforms and cytokines, demonstrating that patients with MS exhibited reduced hypothalamus-pituitary-adrenal axis (HPA) sensitivity to glucocorticoid feedback and that dysregulation of this axis could contribute to pathogenesis of MS.